Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Blood Research
>
2015
>
50
>
1
Volume:
50
Issue:
1
1. Atypical HUS caused by anti-complement factor H antibody: a hematologist's perspective.
Page:63—65
2. Diffuse large B cell lymphoma with high M protein: an unusual finding.
Page:61—62
3. Chronic eosinophilic leukemia with a FIP1L1-PDGFRA rearrangement: Two case reports and a review of Korean cases.
Page:58—61
4. A case of pediatric ALL with t(16;21)(p11.2;q22) and FUS-ERG rearrangement.
Page:55—58
5. Regenerating blasts masquerading as relapse in a patient with ALL following G-CSF therapy.
Page:54—55
6. HBV reactivation in a HBsAg-negative patient with multiple myeloma treated with prednisolone maintenance therapy after autologous HSCT.
Page:51—53
7. Comparative analysis of cellulose acetate hemoglobin electrophoresis and high performance liquid chromatography for quantitative determination of hemoglobin A2.
Page:46—50
8. SOCS1 and SOCS3 are expressed in mononuclear cells in human cytomegalovirus viremia after allogeneic hematopoietic stem cell transplantation.
Page:40—45
9. Anti-leukemic properties of deferasirox via apoptosis in murine leukemia cell lines.
Page:33—39
10. Promoter methylation and expression levels of selected hematopoietic genes in pediatric B-cell acute lymphoblastic leukemia.
Page:26—32
11. Efficacy and safety of eltrombopag in adult refractory immune thrombocytopenia.
Page:19—25
12. Use of lenalidomide in the management of relapsed or refractory multiple myeloma: expert recommendations in Korea.
Page:7—18
13. Spontaneous bilateral suburothelial hemorrhage in immune thrombocytopenic purpura.
Page:6—6
14. Splenic rupture in primary amyloidosis with chronic neutrophilic leukemia.
Page:5—5
15. Is cord blood worth saving for public or private banking?.
Page:3—4
16. Eltrombopag: a new treatment option for chronic refractory adult immune thrombocytopenia.
Page:1—2